AMGEN INC 10-Q filing
Filed 2025-11-05 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0000318154-25-000072
- Form type
- 10-Q
- CIK
- 0000318154
- Primary document
- https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/amgn-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AMGEN INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $26.9B | - | - |
| Cost Of Revenue | $9.1B | - | - |
| Operating Income | $6.4B | - | - |
| Net Income | $6.4B | - | - |
| Eps Basic | 11.86 | - | - |
| Eps Diluted | 11.77 | - | - |
| Cash And Equivalents | $9.4B | - | - |
| Total Assets | $90.1B | - | - |
| Shareholders Equity | $9.6B | - | - |
| Operating Cash Flow | $8.4B | - | - |
| Capital Expenditures | $1.2B | - | - |